Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

TIAPROFENIC ACID vs TILDRAKIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

TIAPROFENIC ACID vs TILDRAKIZUMAB: Safety Overview

Metric TIAPROFENIC ACID TILDRAKIZUMAB
Total FAERS Reports 165 869
Deaths Reported 8 89
Death Rate 4.8% 10.2%
Hospitalizations 115 389
Average Patient Age 35.9 yrs 57.9 yrs
% Female Patients 75.0% 42.5%
Manufacturer N/A Sun Pharmaceutical Industries, Inc.
Route N/A SUBCUTANEOUS